[Review Article] Nanocarriers for Protein and Peptide Drug Delivery

Author:

Al-Hussaniy Hany Akeel,Abed Haithem N,Al-Nayef Ahmed Dahham,Al-Tameemi Sadeq Jaafer,Al-Tameemi Zahraa Salam

Abstract

BACKGROUND: Protein and peptide drugs offer significant promise as therapeutic agents due to their superior efficacy and reduced toxicity compared to conventional chemical drugs. Nevertheless, difficulties with medication delivery techniques impede their practical deployment. Poor absorption limits non-invasive delivery methods such as nasal, pulmonary, and transdermal distribution, whereas oral administration suffers from low bioavailability and stability problems. Parenteral administration involves certain difficulties, such as low patient compliance and pain, but it also shows promise as a protein-based drug delivery method. AIM: This review article aims to explore the development of structure-based nanocarriers designed for drug delivery, which have shown potential to address the limitations associated with protein and peptide drug delivery. MATERIALS AND METHODS: A complete literature review was undertaken utilizing Google Scholar and other trustworthy scientific sources to acquire relevant material for this study. Keywords included in the search were “Nanocarriers”, “bioavailability”, “absorption”, “peptide”, “protein drug delivery”, and “permeability”. This review investigated peer-reviewed publications, research papers, and reviews relating to the issue of inclusion. RESULTS: The review highlights the advancements in structure-based nanocarriers for protein and peptide drug delivery. These nanocarriers have demonstrated reduced side effects and improved therapeutic efficacy compared to free drug molecules. The ability of new and advanced nanocarriers to facilitate targeted drug delivery, overcome physiological barriers, and enable controlled drug release within the body is discussed. CONCLUSION: By developing structure-based nanocarriers, the problems with conventional drug delivery techniques may be addressed, and protein and peptide medication delivery can be improved. Potential benefits of these nanocarriers include enhanced absorption, tailored drug administration, and greater bioavailability, which might result in safer and more successful treatment results for a range of illnesses.

Publisher

Qeios Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3